Phase II, Double-Blind, Vehicle-Controlled Study to Determine the Cantharidin Dose Regimen, Efficacy, Safety, and Tolerability of VP-102 in Subjects with External Genital Warts.
Scott GuenthnerWendy McFaldaMelita TateKimberly EadsJayson RiegerDavid K GloverCynthia WillsonPamela RumneyTed RosenJennifer L AndresMelissa OlivadotiPublished in: American journal of clinical dermatology (2021)
NCT03981822, actual study start date: 25 June, 2019; actual primary completion date: 21 May, 2020; actual study completion date: 8 July, 2020.